Oncoimmunology.

ISSN 2162-4011Taylor and Francis Ltd.United States
ScopusMEDLINEEmbasePubMedPMCSCImagoDOAJJIFMatched via identifier

Journal overview

Journal identity
Titles
OncoImmunology
Oncoimmunology
OncoImmunology TAYLOR & FRANCIS INC
Oncoimmunology.
Oncoimmunology (abbreviated)
Key identifiers
ISSN
2162-4011
2162-402X
eISSN
2162-402X
NLM ID
101570526
Publisher / basic metadata
Publisher
Taylor and Francis Ltd.
Taylor & Francis
Austin, TX : Landes Bioscience
Country
Language
ENG
English

Indexing & coverage

Current indexing summary
Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2012–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCCoverage available

Metrics

MetricYearValueQuartileRankSource
JIF20256.3Q11333JCR Impact Factor List 2025 — supplied dataset
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
2.438
Best Quartile
Q1
H-index
134
Subject categories
  • Immunology — Q1
  • Immunology and Allergy — Q1
  • Oncology — Q1
More metrics
Coverage
2012–2026
Country
United States
Region
Northern America
Publisher
Taylor and Francis Ltd.
Open Access
Yes
Open Access (Diamond)
No
Total documents (current year)
127
Total documents (3 years)
432
Total references
6506
Total citations (3 years)
2744
Citable documents (3 years)
386
Citations per document (2 years)
5.67
References per document
51.23
Source details
Match confidence
Confirmed — two independent ISSNs agree
Matched via ISSN(s)
2162-402X, 2162-4011
SCImago Source ID
21100255413
SCImago Rank (across all SCImago source types)
1014

Publication activity

Publication activity
SCImago
2025
127 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Open access

DOAJ — Directory of Open Access Journals

Source: DOAJ (Directory of Open Access Journals). Listing status and policy details are reported here as DOAJ published them.

Listed in DOAJ
Yes
License
CC BY, CC BY-NC
APC (article processing charge)
3300 USD; 2640 GBP; 3170 EUR; 4595 AUD
More information
Waiver policy
Yes
Review process
Anonymous peer review
Plagiarism screening
Yes
Preservation services
CLOCKSS, LOCKSS, PMC, Portico, Scholars Portal
Added to DOAJ
2020-05-11
Journal homepage
DOAJ profile
Source details
Match confidence
Probable — one matching ISSN
Matched via ISSN(s)
2162-402X

Subjects & categories

Subjects / categories
Subject area (SCImago)
MeSH (PubMed)
Immunotherapy; Neoplasms/therapy
Coverage / history
Scopus:2012-2026
MEDLINE:MEDLINE: v9n1, 2020-In: PubMed: v3n1, 2014- ; Selected citations only before this date, PMC;
PubMed:MEDLINE: v9n1, 2020-In: PubMed: v3n1, 2014- ; Selected citations only before this date, PMC;
PMC:v.1(1) 2012 – v.15(1) 2026